[
  {
    "sentence": "Mice harbouring established NFpp10-GBM tumours were treated with intravenous injections of LIGHT–CGKRK fusion compound twice weekly for 2weeks (Figure 2A), and this was followed by histological analysis of tumour stroma.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "LIGHT–VTP therapy at a dose of 20ng per mouse (≈600ng/kg body weight) significantly reduced tumour vessel length and diameter as compared with untreated GBM, to a level resembling the calibre of normal brain capillaries (Figure 2B–D).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Importantly, overall vascularity was not reduced, indicating that single LIGHT–CGKRK treatment did not destroy tumour vessels (Figure 2E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel E",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel E",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "LIGHT–VTP treatment did not change the number of pericytes that were attached to endothelial cells as compared with untreated tumours, as shown by quantification of desmin-positive pericytes surrounding CD31+ tumour blood vessels (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Under LIGHT–VTP treatment, all contractile markers were significantly upregulated, whereas synthesis of the extracellular matrix marker collagen I was reduced (Figure 3B–E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "NS, not statistically significant.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Mice harbouring established NFpp10-GBM tumours were treated with intravenous injections of LIGHT–CGKRK fusion compound twice weekly for 2weeks (Figure 2A), and this was followed by histological analysis of tumour stroma.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "LIGHT–VTP therapy at a dose of 20ng per mouse (≈600ng/kg body weight) significantly reduced tumour vessel length and diameter as compared with untreated GBM, to a level resembling the calibre of normal brain capillaries (Figure 2B–D).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Importantly, overall vascularity was not reduced, indicating that single LIGHT–CGKRK treatment did not destroy tumour vessels (Figure 2E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel E",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel E",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "LIGHT–VTP treatment did not change the number of pericytes that were attached to endothelial cells as compared with untreated tumours, as shown by quantification of desmin-positive pericytes surrounding CD31+ tumour blood vessels (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Under LIGHT–VTP treatment, all contractile markers were significantly upregulated, whereas synthesis of the extracellular matrix marker collagen I was reduced (Figure 3B–E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  }
]